Tamoxifen

CAS No.:10540-29-1

TBW04221
tamoxifen drug standard solution;tamoxifen free base;Genox;Kessar;Nolvadex;Nolvadex-D;Tamoxen;Tamoxifen;(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;Tamoxifen ( ICI-46474);Tamoxifen Citrate(Nolvadex);Taxmoxifen;(Z)-1-{4-[2-(dimethylamino)ethoxy]-phenyl}-1,2-diphenyl-1-butene;(Z)-2-[4-(1, 2-Diphenyl-1-butenyl)-phenoxy] -N, N- diMethylethanaMine;[14C]-Tamoxifen;[3H]-Tamoxifen;1-p-β-DiMethylaMinoethoxyphenyl-trans-1,2-diphenylbut-1-ene;Citofen;Crisafeno;Diemon;ICI47699;Oncomox;Soltamox;Tamizam;TaMoxifen-3-14C;Tamoxifene;trans-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;trans-Tamoxifen;Valodex;Z-Tamoxifen;C07108;Mammaton;Novaldex;TaMoxiefen;Tamoxifenum;Tamoxifeno;Istubol;Retaxim;Tamoxifenum [INN-Latin];Tamoxifene [INN-French];Tamoxifeno [INN-Spanish];Tamoxifen (Z);Tamoxifen and its salts;Tamoxifen [INN:BAN];ICI 47699;TRANS FORM OF TAMOXIFEN;1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene;1-para-beta-Dimethylaminoethoxyphenyl-trans-1,;(Z)-Tamoxifen;trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;ici47699;TAMOXIFEN;z-tamoxifen;HB0601;NCGC00024928-11;NCGC00024928-40;Tamoxifeno (INN-Spanish);SDCCGSBI-0051170.P007;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine;GTPL1016;NCGC00024928-15;BRD-K93754473-001-02-9;(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine;AB00053547_20;HSDB 6782;Spectrum5_002043;1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene;NCGC00024928-16;Tocris-0999;Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-;Z2527624834;Prestwick3_000146;MLS001332535;TAMOXIFEN [WHO-DD];L024126;BRD-K93754473-048-10-3;(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene;NCGC00024928-13;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine;BIDD:GT0009;Tamoxifen, analytical standard;(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine;TAMOXIFEN [VANDF];Tamoxifen, certified reference material, TraceCERT(R);NCGC00024928-03;NCGC00024928-39;1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene;Tamoxifen (INN);AM84324;2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine;cMAP_000044;(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)phenoxy)-N,N-dimethylethanamine;UPCMLD-DP027;NCGC00024928-04;Q412178;EN300-1273241;Tox21_500494;A801229;EINECS 234-118-0;HMS2232C12;(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine;Prestwick2_000146;Tamoxifen, >=99%;Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-;W-108788;TAMOXIFEN [INN];C26H29NO;SMR000059172;(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC);CHEBI:41774;1ya4;HMS2090N08;HMS1362J11;HY-13757A;LP00494;[3H]tamoxifen;Tox21_300539;AKOS022143035;HY-13757AR;NCGC00024928-01;NCGC00261179-01;ICI-47699;Tam...
inquiry
C26H29NO
371.51

Product introduction

Solubility: Insoluble in water. Soluble in methanol, ethanol, propanol or propylene glycol.Soluble in dimethyl sulfoxide, dichloromethane and ethanol. Insoluble in water.
Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: O(C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C1C([H])=C([H])C(=C([H])C=1[H])/C(/C1C([H])=C([H])C([H])=C([H])C=1[H])=C(\C1C([H])=C([H])C([H])=C([H])C=1[H])/C([H])([H])C([H])([H])[H]